Differing T-cell requirements for recombinant retrovirus vaccines - PubMed (original) (raw)

Differing T-cell requirements for recombinant retrovirus vaccines

K J Hasenkrug et al. J Virol. 1996 Jan.

Abstract

Friend murine leukemia virus is a retrovirus complex that induces rapid erythroleukemia and immunosuppression in susceptible strains of adult mice. Using this model, we directly examined the T-cell subsets required for a protective retrovirus vaccine. Paradoxically, recovery in mice immunized with a chimeric envelope containing only T-helper (TH) and B-cell epitopes was dependent on CD8+ T cells as well as CD4+ T cells despite the fact that the vaccine contained no CD8+ cytolytic T-lymphocyte (CTL) epitopes. However, the requirement for CD8+ T cells was overcome by inclusion of additional TH and B-cell epitopes in the immunizing protein. These additional epitopes primed for more rapid production of virus-neutralizing antibody which appeared to limit virus spread sufficiently to protect even in the absence of CD8+ T cells. Inclusion of an immunodominant CTL epitope in the vaccine was not sufficient to overcome dependence on CD4+ T cells. These data suggest that TH priming is more critical for retrovirus immunity than CTL priming.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1976 Jan 1;143(1):85-99 - PubMed
    1. Nature. 1994 Aug 11;370(6489):463-7 - PubMed
    1. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5784-8 - PubMed
    1. J Virol. 1980 Jan;33(1):475-86 - PubMed
    1. Biochim Biophys Acta. 1980 Sep 22;605(3):305-24 - PubMed

MeSH terms

Substances

LinkOut - more resources